Avanos Medical (AVNS) Cash from Financing Activities (2016 - 2024)
Historic Cash from Financing Activities for Avanos Medical (AVNS) over the last 12 years, with Q4 2024 value amounting to -$27.4 million.
- Avanos Medical's Cash from Financing Activities rose 7611.16% to -$27.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$49.1 million, marking a year-over-year increase of 4787.69%. This contributed to the annual value of -$49.1 million for FY2024, which is 4787.69% up from last year.
- As of Q4 2024, Avanos Medical's Cash from Financing Activities stood at -$27.4 million, which was up 7611.16% from -$16.0 million recorded in Q3 2024.
- In the past 5 years, Avanos Medical's Cash from Financing Activities registered a high of $105.7 million during Q1 2022, and its lowest value of -$114.7 million during Q4 2023.
- Moreover, its 5-year median value for Cash from Financing Activities was -$10.2 million (2022), whereas its average is -$11.2 million.
- In the last 5 years, Avanos Medical's Cash from Financing Activities crashed by 6820000.0% in 2020 and then skyrocketed by 5295000.0% in 2022.
- Over the past 5 years, Avanos Medical's Cash from Financing Activities (Quarter) stood at -$68.3 million in 2020, then soared by 62.23% to -$25.8 million in 2021, then rose by 15.12% to -$21.9 million in 2022, then plummeted by 423.74% to -$114.7 million in 2023, then skyrocketed by 76.11% to -$27.4 million in 2024.
- Its Cash from Financing Activities stands at -$27.4 million for Q4 2024, versus -$16.0 million for Q3 2024 and -$5.0 million for Q2 2024.